MedTrace Logo

VIrtual Care To Improve Outcomes and RecoverY From Heart Failure Hospitalization

NCT05724433 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 891

Last updated 2024-12-31

No results posted yet for this study

Summary

The clinic visits (intervention) will continue for 90 days, which represents the follow-up period for the primary medication and health status outcomes. The co-primary clinical outcomes will be obtained at 180 days.

Conditions

Interventions

OTHER

Virtual HF Care

Patients will receive virtual visits for 3 months following hospitalization / emergency department (ED) visit for HF. Physiologic measures will be monitored remotely and therapies will be optimized.

OTHER

Routine HF Care

Care as determined by the treating physician

Sponsors & Collaborators

  • Hamilton Health Sciences Corporation

    collaborator OTHER

  • McMaster University

    collaborator OTHER

  • Population Health Research Institute

    lead OTHER

Principal Investigators

  • Harriette Van Spall, MD · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-23
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • Canada
  • Tunisia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05724433 on ClinicalTrials.gov